Scienze Radiologiche, Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy.
Department of Radiology, Kaiser Permanente Northern California, San Leandro, California, USA.
Br J Radiol. 2022 May 1;95(1133):20200260. doi: 10.1259/bjr.20200260. Epub 2022 Jan 7.
Lung cancer screening (LCS) by low-dose computed tomography is a strategy for secondary prevention of lung cancer. In the last two decades, LCS trials showed several options to practice secondary prevention in association with primary prevention, however, the translation from trial to practice is everything but simple. In 2020, the European Society of Radiology and European Respiratory Society published their joint statement paper on LCS. This commentary aims to provide the readership with detailed description about hurdles and potential solutions that could be encountered in the practice of LCS.
肺癌筛查(LCS)采用低剂量计算机断层扫描(LDCT),是肺癌二级预防的策略之一。在过去的二十年中,LCS 试验显示了多种选择,以与初级预防相关联的方式进行二级预防,但从试验到实践的转化却并非易事。2020 年,欧洲放射学会和欧洲呼吸学会发表了他们关于 LCS 的联合声明文件。本评论旨在为读者详细描述在 LCS 实践中可能遇到的障碍和潜在解决方案。